Khelvin Jocson/LinkedIn
Feb 5, 2026, 09:00
Khelvin Jocson: Using LPA to Guide Aspirin Decisions in Primary Prevention
Khelvin Jocson, Advanced Clinical Practitioner in Cardiology at Royal Surrey NHS Foundation Trust, shared a post on LinkedIn about recent article by H. Robert Superko published in American Journal of Preventive Cardiology adding:
“Suggests aspirin guidelines in primary prevention need to be more individualised, rather than one-size-fits-all mindset, with LPA helping to guide that choice.”
Title: The aspirin heart disease prevention conundrum
Authors: H. Robert Superko, John Sninsky, Brenda Garrett
Read the Full Article on American Journal of Preventive Cardiology.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters